Please login to the form below

Not currently logged in
Email:
Password:

Aliqopa

This page shows the latest Aliqopa news and features for those working in and with pharma, biotech and healthcare.

Novartis considers filings for PI3K drug in breast cancer

Novartis considers filings for PI3K drug in breast cancer

years and was recently joined on the market by Bayer’s Aliqopa (copanlisib), also for blood cancers.

Latest news

  • Bayer bags speedy US approval for lymphoma drug Aliqopa Bayer bags speedy US approval for lymphoma drug Aliqopa

    Bayer bags speedy US approval for lymphoma drug Aliqopa. FDA decision sets the pharma firm up for a showdown with Gilead's Zydelig. ... The FDA has approved Bayer's PI3K inhibitor Aliqopa, setting up a market showdown with Gilead Sciences' Zydelig in

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cello Health Insight

Cello Health Insight is the global market research arm of Cello Health. With 35 years’ sector experience, we specialise in...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics